China Universal Asset Management Co., Ltd. Pacira Bio Sciences, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 9,790 shares of PCRX stock, worth $251,211. This represents 0.02% of its overall portfolio holdings.
Number of Shares
9,790
Previous 8,872
10.35%
Holding current value
$251,211
Previous $133,000
38.35%
% of portfolio
0.02%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding PCRX
# of Institutions
257Shares Held
48.4MCall Options Held
429KPut Options Held
391K-
Black Rock Inc. New York, NY8.01MShares$205 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.3MShares$136 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$83.7 Million0.15% of portfolio
-
State Street Corp Boston, MA2.01MShares$51.7 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.98MShares$50.8 Million0.05% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.18B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...